Zacks Investment Research downgraded shares of Olympus Corp. (OTCMKTS:OCPNY) from a buy rating to a hold rating in a report issued on Saturday morning.

According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “

Shares of Olympus Corp. (OCPNY) traded up $0.44 during midday trading on Friday, reaching $38.29. 3,299 shares of the company’s stock traded hands, compared to its average volume of 4,969. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.28 and a current ratio of 1.78. Olympus Corp. has a 1 year low of $33.17 and a 1 year high of $39.49. The firm has a market cap of $13,121.64, a PE ratio of 22.93, a P/E/G ratio of 3.47 and a beta of 1.07.

ILLEGAL ACTIVITY NOTICE: “Olympus Corp. (OCPNY) Downgraded by Zacks Investment Research to Hold” was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at

About Olympus Corp.

Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.

Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.